Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010559
Filing Date
2020-08-13
Accepted
2020-08-13 16:45:32
Documents
63
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20200630x10q.htm 10-Q 1408419
2 EX-31.1 rsls-20200630ex31154c94b.htm EX-31.1 11656
3 EX-31.2 rsls-20200630ex312921916.htm EX-31.2 11963
4 EX-32.1 rsls-20200630ex3212788d1.htm EX-32.1 9386
5 EX-32.2 rsls-20200630ex32289c14c.htm EX-32.2 9260
  Complete submission text file 0001558370-20-010559.txt   4663651

Data Files

Seq Description Document Type Size
6 EX-101.INS rsls-20200630.xml EX-101.INS 746154
7 EX-101.SCH rsls-20200630.xsd EX-101.SCH 36204
8 EX-101.CAL rsls-20200630_cal.xml EX-101.CAL 54684
9 EX-101.DEF rsls-20200630_def.xml EX-101.DEF 136600
10 EX-101.LAB rsls-20200630_lab.xml EX-101.LAB 310198
11 EX-101.PRE rsls-20200630_pre.xml EX-101.PRE 274438
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

EIN.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33818 | Film No.: 201099953
SIC: 3845 Electromedical & Electrotherapeutic Apparatus